3 High-Yield Pharmaceutical Stocks
Pharmaceutical stocks are generally an outstanding place to look for sustainable sources of passive income. Even though most companies offer fairly modest yields due to the costly nature of developing new drugs, there are a handful of big pharma stocks that do sport surprisingly high yields.
With this theme in mind, we asked three Motley Fool investors which high-yield pharma stocks might be worth buying right now. They recommended GlaxoSmithKline (NYSE: GSK), Pfizer (NYSE: PFE), and Johnson & Johnson (NYSE: JNJ).
Image source: Getty Images.
Source: Fool.com
Pfizer Inc. Aktie
21,71 €
0,79 %
Mehrere Buy-Einschätzungen für Pfizer Inc., die die Sell-Einschätzungen übersteigen.
Ein Kursziel von 29 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 21.71 € bedeuten.
